Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
phenylephrine alpha-1a adrenergic receptor small molecule NA drugbank , DGIDB Hypotension[MeSHID:D007022]
Priapism[MeSHID:D011317]
Regional Blood Flow[MeSHID:D012039]
Pupil[MeSHID:D011680]
Vascular constriction (function)[MeSHID:D014661]
Shock[MeSHID:D012769]
Eye[MeSHID:D005123]
Hemorrhoids[MeSHID:D006484]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Thyroid associated opthalmopathies[MeSHID:D049970]
Fecal Incontinence[MeSHID:D005242]
0.25 approved agonist
phenylephrine alpha-1b adrenergic receptor small molecule NA drugbank , DGIDB Hypotension[MeSHID:D007022]
Priapism[MeSHID:D011317]
Regional Blood Flow[MeSHID:D012039]
Pupil[MeSHID:D011680]
Vascular constriction (function)[MeSHID:D014661]
Shock[MeSHID:D012769]
Eye[MeSHID:D005123]
Hemorrhoids[MeSHID:D006484]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Thyroid associated opthalmopathies[MeSHID:D049970]
Fecal Incontinence[MeSHID:D005242]
0.29 approved agonist
phenylephrine alpha-1d adrenergic receptor small molecule NA drugbank , DGIDB Hypotension[MeSHID:D007022]
Priapism[MeSHID:D011317]
Regional Blood Flow[MeSHID:D012039]
Pupil[MeSHID:D011680]
Vascular constriction (function)[MeSHID:D014661]
Shock[MeSHID:D012769]
Eye[MeSHID:D005123]
Hemorrhoids[MeSHID:D006484]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Thyroid associated opthalmopathies[MeSHID:D049970]
Fecal Incontinence[MeSHID:D005242]
0.19 approved agonist
phenylephrine dopamine d2 receptor NA Successful target TTD , DGIDB Hypotension[MeSHID:D007022]
Priapism[MeSHID:D011317]
Regional Blood Flow[MeSHID:D012039]
Pupil[MeSHID:D011680]
Vascular constriction (function)[MeSHID:D014661]
Shock[MeSHID:D012769]
Eye[MeSHID:D005123]
Hemorrhoids[MeSHID:D006484]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Thyroid associated opthalmopathies[MeSHID:D049970]
Fecal Incontinence[MeSHID:D005242]
0.03 approved unknown
click here to return to the previous page